Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Oncoustics is pioneering the development and application of innovative, patented AI technologies aimed at providing low-cost, non-invasive surveillance, diagnostics, and treatment monitoring for diseases that currently face significant clinical challenges. The company has developed a range of specialized applications focused on various diseases and anatomical structures that are compatible with any point-of-care ultrasound device, allowing physicians, nurses, and technicians to operate them as essential tools in a primary care setting without requiring image analysis. By leveraging AI, Oncoustics transforms affordable point-of-care ultrasound machines into robust diagnostic instruments capable of facilitating quick and economical identification and monitoring of conditions affecting the liver, prostate, kidney, breast, and thyroid. The multidisciplinary team behind Oncoustics consists of professionals with expertise in AI, signal processing, radiology, hepatology, digital health, and ultrasound, ensuring a comprehensive approach to healthcare innovation. The emphasis on cost-effective point-of-care diagnostics and surveillance significantly enhances patient outcomes through timely detection and consistent monitoring, which are crucial for effective disease management and better overall health. As such, Oncoustics is not only addressing immediate healthcare needs but is also setting the stage for a transformation in how we approach disease management in the future.
Description
SeqOne is an advanced genomic analysis platform powered by artificial intelligence, aimed at enabling molecular laboratories, clinical teams, biologists, and geneticists to convert intricate next-generation sequencing data into quick, accurate, and actionable clinical insights that aid in personalized medicine diagnostics. By streamlining the entire genomic workflow—from handling raw sequencing data to variant interpretation and reporting—this platform automates routine tasks, integrates smoothly with laboratory systems, and employs sophisticated AI models like DiagAI to assess and prioritize disease-related variants, thereby minimizing manual labor and shortening turnaround times. SeqOne is versatile, catering to both germline and somatic analyses across various fields such as oncology, rare inherited diseases, and infectious disease detection, while it combines high-quality annotation databases and standardized interpretation protocols to ensure clinical-grade precision. Furthermore, it features an intuitive user interface that can scale securely through the cloud, making it accessible and efficient for diverse clinical environments. Ultimately, SeqOne represents a significant advancement in genomic analysis technology, fostering enhanced diagnostic capabilities in the realm of personalized medicine.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Oncoustics
Country
Canada
Website
oncoustics.com
Vendor Details
Company Name
SeqOne
Founded
2017
Country
France
Website
www.seqone.com